This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Lonza Walkersville, Inc., Other. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Leben Tadesse: Innovator in Limulus Amebocyte Lysate Technology
Introduction
Leben Tadesse is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of compositions involving clarified limulus amebocyte lysate (LAL). With a total of 2 patents to his name, Tadesse's work has implications for endotoxin detection and related applications.
Latest Patents
Tadesse's latest patents focus on coagulogen-free clarified limulus amebocyte lysate. The first patent describes compositions comprising clarified LAL that is substantially free of coagulogen, along with methods for making such compositions. This invention also outlines a method for detecting endotoxins in samples using a chromogenic assay. The process involves contacting the sample with a reagent that includes clarified LAL and a chromogenic substrate, followed by measuring the chromogenic effect resulting from the presence of endotoxin. Additionally, the invention includes kits that utilize clarified LAL free of coagulogen.
Career Highlights
Throughout his career, Leben Tadesse has worked with various companies, including Lonza Walkersville, Inc. His expertise in biotechnology has allowed him to contribute to advancements in the detection of endotoxins, which is crucial for ensuring the safety of medical products.
Collaborations
Tadesse has collaborated with professionals such as Candice Stumbaugh and Karen Lin, enhancing the innovation process through teamwork and shared expertise.
Conclusion
Leben Tadesse's contributions to biotechnology, particularly in the area of clarified limulus amebocyte lysate, demonstrate his commitment to advancing medical safety and innovation. His patents reflect a significant step forward in endotoxin detection methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile